Taiwan registry for people treated for hepatitis C
Part of Digestive system, Infections clinical trials.
This registry is for people in Taiwan who have received direct-acting antiviral (DAA) treatment for hepatitis C. It collects health information to better understand outcomes and care, and you can join if you agree to participate and sign consent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been treated for hepatitis C with DAA medicines
- You are willing to participate in a long-term health information registry
- You agree to sign written informed consent
- You are likely able to provide participation details as requested by the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a pregnancy registry that collects information about people who have hepatitis C during pregnancy and took hepatitis C medicines early in pregnancy. It aims to better understand the safety and outcomes of treatment around conception.
This is a registry-based study that collects information from adults who have hepatitis D infection confirmed by a positive RNA test. It may help researchers better understand hepatitis D in real-world patients and guide future care.
This study is a registry, meaning it collects health information from people living with hepatitis B rather than giving a new treatment. It may help researchers better understand different hepatitis B groups and outcomes over time.
This trial is for people who use drugs and have hepatitis C. It tests an approach to help treat and manage hepatitis C in a supportive way.
This study looks at a step-by-step process to screen for hepatitis C, treat it, and help people clear the virus. If you meet the basic requirements, joining could help ensure you get evaluated and, if eligible, treated in a structured way.
This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.
Hear when a new Hepatitis C, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.